Frequent gain of copy number on the long arm of chromosome 20 in human pancreatic adenocarcinoma
暂无分享,去创建一个
F. Waldman | T. Furukawa | A. Horii | S. Fukushige | M. Sunamura | M. Kobari | T. Abe | M. Kimura
[1] A. Horii,et al. Detailed deletion mapping on chromosome arm 12q in human pancreatic adenocarcinoma: Identification of a 1‐cM region of common allelic loss , 1996, Genes, chromosomes & cancer.
[2] Scott E. Kern,et al. DPC4, A Candidate Tumor Suppressor Gene at Human Chromosome 18q21.1 , 1996, Science.
[3] R. Hruban,et al. Allelotype of pancreatic adenocarcinoma using xenograft enrichment. , 1995, Cancer research.
[4] S. Hilsenbeck,et al. Genetic aberrations detected by comparative genomic hybridization predict outcome in node-negative breast cancer. , 1995, The American journal of pathology.
[5] H. Döhner,et al. Comparative genomic hybridization in chronic B-cell leukemias shows a high incidence of chromosomal gains and losses. , 1995, Blood.
[6] S. Bohlander,et al. Consistent chromosome abnormalities in adenocarcinoma of the pancreas. , 1995, Cancer research.
[7] W. Kuo,et al. A physical map of chromosome 20 established using fluorescence in situ hybridization and digital image analysis. , 1995, Genomics.
[8] S. Devries,et al. Identification of gains and losses of DNA sequences in primary bladder cancer by comparative genomic hybridization , 1995, Genes, chromosomes & cancer.
[9] S. Devries,et al. Analysis of changes in DNA sequence copy number by comparative genomic hybridization in archival paraffin-embedded tumor samples. , 1994, The American journal of pathology.
[10] R. Hruban,et al. Frequent somatic mutations and homozygous deletions of the p16 (MTS1) gene in pancreatic adenocarcinoma , 1994, Nature Genetics.
[11] W. Kuo,et al. Increased copy number at 20q13 in breast cancer: defining the critical region and exclusion of candidate genes. , 1994, Cancer research.
[12] R. Hruban,et al. p53 mutations in pancreatic carcinoma and evidence of common involvement of homocopolymer tracts in DNA microdeletions. , 1994, Cancer research.
[13] N. Pellegata,et al. K-ras and p53 gene mutations in pancreatic cancer: ductal and nonductal tumors progress through different genetic lesions. , 1994, Cancer research.
[14] J Piper,et al. Detection and mapping of amplified DNA sequences in breast cancer by comparative genomic hybridization. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[15] S. Goodman,et al. K-ras oncogene activation in adenocarcinoma of the human pancreas. A study of 82 carcinomas using a combination of mutant-enriched polymerase chain reaction analysis and allele-specific oligonucleotide hybridization. , 1993, The American journal of pathology.
[16] Y. Nakamura,et al. High-resolution cytogenetic mapping of 342 new cosmid markers including 43 RFLP markers on human chromosome 17 by fluorescence in situ hybridization. , 1993, Genomics.
[17] F. Mitelman,et al. Karyotypic abnormalities in tumours of the pancreas. , 1993, British Journal of Cancer.
[18] A. Andrén-sandberg,et al. Nonrandom chromosomal rearrangements in pancreatic carcinomas , 1992, Cancer.
[19] A. Tanigami,et al. Allelotype of breast cancer: cumulative allele losses promote tumor progression in primary breast cancer. , 1990, Cancer research.
[20] D. Shibata,et al. Most human carcinomas of the exocrine pancreas contain mutant c-K-ras genes , 1988, Cell.
[21] D M Parkin,et al. Estimates of the worldwide frequency of sixteen major cancers in 1980 , 1988, International journal of cancer.
[22] M. Kan,et al. Establishment of six human pancreatic cancer cell lines and their sensitivities to anti-tumor drugs. , 1986, The Tohoku journal of experimental medicine.
[23] S. Matsuno,et al. Recent Advances in Diagnosis and Surgical Treatment of Pancreatic Cancer , 1993 .